Form DEL AM 60 DEGREES PHARMACEUTICA

 

60 Degrees Pharmaceuticals, Inc.

1025 Connecticut Avenue NW Suite 1000

Washington, D.C. 20036

(202) 327-5422

 

August 17, 2026                       

 

Via EDGAR

 

Securities and Exchange Commission

100 F Street, NE

Washington, D.C. 20549

 

Re: 60 Degrees Pharmaceuticals, Inc. Registration Statement on Form S-3 (File No. 333-298349) filed on August 14, 2026

 

Ladies and Gentlemen:

 

Reference is made to the Registration Statement on Form S-3 (File No. 333-298349) filed by 60 Degrees Pharmaceuticals, Inc. on August 14, 2026 (the “Registration Statement”).

 

Pursuant to Rule 473(c) of the Securities Act of 1933, as amended (the “Act”), the following delaying amendment, prescribed by Rule 473(a) of the Act, is hereby incorporated onto the facing page of the Registration Statement:

 

“The registrant hereby amends this registration statement on such date or dates as may be necessary to delay its effective date until the registrant shall file a further amendment which specifically states that this registration statement shall thereafter become effective in accordance with Section 8(a) of the Securities Act of 1933, as amended, or until this registration statement shall become effective on such date as the SEC, acting pursuant to said Section 8(a) may determine.”

 

Should you have any questions regarding the Registration Statement, please feel free to contact the undersigned at (516) 668-4553.

 

Yours sincerely,
/s/ Jesse L. Blue, Esq.
Jesse L. Blue, Esq.

 

 

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Tempest Surge Records Expands Artist-Development Vision as Flagship Artist B-Ret Surpasses 3 Million Cross-Platform Streams and Views
• Next Shiba Inu With 100x Potential? Best Crypto Presale AlphaPepe Has $2.57M Raised Without a Public Candle Yet
• Govee Ushers in the Next Era of Smart Living with AI-Powered Lighting Innovation at IFA 2026